Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Fármacos antipsicóticos de segunda generación para el trastorno depresivo mayor y la distimia

Información

DOI:
https://doi.org/10.1002/14651858.CD008121.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Katja Komossa

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Anna M Depping

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Andrea Gaudchau

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Correspondencia a: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

    [email protected]

Contributions of authors

Katja Komossa: protocol development, searching, study selection, data extraction, report writing.

Anna Mareike Depping: protocol development, study selection, data extraction.

Stefan Leucht: protocol development, searching, study selection, data extraction, report writing.

Werner Kissling: protocol development.

Andrea Gaudchau: helped with data extraction and writing.

Sources of support

Internal sources

  • Freistaat Bayern, Germany.

External sources

  • Bundesministerium für Bildung und Forschung Nr 01KG08188816529, Germany.

Declarations of interest

Katja Komossa: none to declare.

Stefan Leucht: received speaker/consultancy/advisory board honoraria from Sanofi‐Aventis, BMS, Eli Lilly, Glaxo Smith Kline, Essex, Janssen/Johnson and Johnson, Lundbeck and Pfizer. Sanofi‐Aventis and Eli Lilly supported research projects by Stefan Leucht.

Werner Kissling: received speaker or consultancy honoraria from Sanofi‐Aventis, BMS, Eli Lilly, Janssen, Lundbeck, Bayer and Pfizer.

Anna Mareike Depping: none to declare.

Acknowledgements

We would like to thank all members of the Cochrane Depression, Anxiety and Neurosis editorial team for their assistance. We would also like to thank C. Li for his help with the Chinese studies. We thank the pharmaceutical companies Astra Zeneca, BMS, Janssen‐Cilag, Pfizer and Sanofi‐Aventis for providing additional information.

Version history

Published

Title

Stage

Authors

Version

2010 Dec 08

Second‐generation antipsychotics for major depressive disorder and dysthymia

Review

Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008121.pub2

2009 Oct 07

Second‐generation antipsychotic drugs for major depressive disorder

Protocol

Katja Komossa, Anna M Depping, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008121

Differences between protocol and review

'Dysthymia' was added to title.